Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0383820110700050405
Tuberculosis and Respiratory Diseases
2011 Volume.70 No. 5 p.405 ~ p.415
The Effect of Tissue Plasminogen Activator on TGF-¥â1 Pre-Treated Human Mesothelial Cell Line
Lee Jung-Lim

Jeon Soo-Jin
Yoo Young-Choon
Kim Ji-Hye
Lee Yu-Mi
Kwon Sun-Jung
Son Ji-Woong
Choi Eu-Gene
Na Moon-Jun
Abstract
Background: In an effort to find alternative therapeutic agents to prevent excessive fibrosis as a sequela to
complicated parapneumonic effusion or empyema, we examined the effect of tissue plasminogen activator (tPA)
as a fibrinolytic agent combined with talc or transforming growth factor (TGF)-¥â1 in a human pleural mesothelial
cell line, MeT-5A.

Methods: MeT-5A cells were stimulated with various doses of talc, doxycycline or TGF-¥â1 for 24 h and then
were treated with tPA for an additional 24 h. Cell viability was measured by MTT assay. The production of interleukin (IL)-8 and vascular endothelial growth factor (VEGF) in the culture supernatants was measured by ELISA. Real-time PCR was carried out for measurement of type I collagen mRNA.

Results: MeT-5A cells treated with talc showed a dose-dependent increase in production of IL-8. Talc also increased production of type I collagen mRNA at low doses, but talc did not influence the induction of VEGF. Addition
of tPA to talc-stimulated cells showed further increases in the production of IL-8, but tPA did not influence the production of VEGF or type I collagen mRNA. TGF-¥â1 increased the production of both VEGF and collagen type I mRNA, both of which were effectively inhibited by additional tPA treatment in MeT-5A cells.

Conclusion: TGF-¥â1 is a potent inducer of collagen synthesis without induction of IL-8 in MeT-5A cells. Addition
of tPA after TGF-¥â1 stimulation inhibited further fibrosis by direct inhibition of collagen mRNA synthesis as well as by inhibition of VEGF production.
KEYWORD
Humans, Mesothelium, Cell Line, Tissue Plasminogen Activator, Transforming Growth Factor, Collagen
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø